AVO.L Share News (AVO)
AVO Share
AVO Share
AVO Share
AVO Share
AVO
AVO Share
AVO Broker
AVO Directors
AVO Financial
AVO
AVO Short
AVO
Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Non-Executive Director Michael Bradfield buys 500,000 shares at 13.17 pence, worth GBP65,825, on Thursday. Now has 8.4 million shares, a 1.6% stake.
Read more(Alliance News) - Advanced Oncotherapy PLC on Monday said that a recently-completed study has shown the potential superiority of its proton therapy in treating breast cancer patients.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more
(Sharecast News) - Proton therapy developer Advanced Oncotherapy announced it was raising £1.47m through a direct subscription on Friday, to fund its corporate activities as it moves its 'LIGHT' system towards full operation.
Read more(Alliance News) - Shares in Advanced Oncotherapy PLC jumped on Friday following its announcement of a GBP1.5 million equity fundraise.
Read moreAdvanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Raises GBP550,691 through direct subscription of 2.2 million shares at a price of 25 pence per share.
Read more(Alliance News) - The following is a round-up of earnings reports by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read moreAdvanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Raises GBP6.0 million before expenses in subscription for 24.1 million shares at 25 pence each. The issue price was a premium of 19% to the closing middle market price of a share on Monday. Notes Odey Asset Management LLP subscribed for GBP4.5 million in shares, on behalf of some of its funds.
Read moreAdvanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Says it has made "significant" progress with the commissioning of the Light system. This includes Light system beam being optimised to a sub-millimetre size, with a beam current of about 50 microamperes; and 20 of the 21 accelerating modules have been radio-frequency conditioned.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
Read more(Sharecast News) - Proton therapy technology developer Advanced Oncotherapy announced an equity fundraise of £2m on Friday, to fund itself along its revised timetable for the development of the 'LIGHT' cancer therapy system.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:
Read moreTRADING UPDATES: Avation wings clipped by virus; Zaim swings to profit
Read moreTRADING UPDATES: Ince launches solution; PureTech gets USD6.5 million
Read more
